References
- National Center for Chronic Disease Prevention and Health Promotion. About chronic diseases. [accessed 2021 July]. https://www.cdc.gov/chronicdisease/about/index.htm .
- World Health Organization. Noncommunicable diseases: Country profiles 2018; 2018. [accessed 2021 July]. https://www.who.int/health-topics/noncommunicable-diseases#tab=tab_1 .
- World Health Organization. Noncommunicable diseases - Fact sheet. Geneva: World Health Organization; 2021. [accessed 2021 July]. https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases .
- GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1736–13. doi:10.1016/S0140-6736(18)32203-7.
- Menon GR, Singh L, Sharma P, Yadav P, Sharma S, Kalaskar S, Singh H, Adinarayanan S, Joshua V, Kulothungan V, et al. National burden estimates of healthy life lost in India, 2017: an analysis using direct mortality data and indirect disability data. Lancet Glob Health. 2019;7(12):e1675–84. doi:10.1016/S2214-109X(19)30451-6.
- GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018;392(10159):1789–858. doi:10.1016/S0140-6736(18)32279-7.
- GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020;395(10225):709–33. PMC7049905. doi:10.1016/s0140-6736(20)30045-3.
- World Health Organization. Global health and aging; 2011. [accessed 2021 July]. https://www.who.int/ageing/publications/global_health.pdf?ua=1 .
- Corrales-Medina VF, Alvarez KN, Weissfeld LA, Angus DC, Chirinos JA, Chang CCH, Newman A, Loehr L, Folsom AR, Elkind MS, et al. Association between hospitalization for pneumonia and subsequent risk of cardiovascular disease. JAMA. 2015;313(3):264–74. doi:10.1001/jama.2014.18229.
- Wu PH, Lin YT, Lin CY, Huang MY, Chang WC, Chang WP. A nationwide population-based cohort study to identify the correlation between heart failure and the subsequent risk of herpes zoster. BMC Infect Dis. 2015;15(1):17. doi:10.1186/s12879-015-0747-9.
- Hak E, Verheij TJM, van Essen GA, Lafeber AB, Grobbee DE, Hoes AW. Prognostic factors for influenza-associated hospitalisation and death during an epidemic. Epidemiol Infect. 2001;126(2):261–68. doi:10.1017/S0950268801005180.
- Panhwar MS, Kalra A, Gupta T, Kolte D, Khera S, Bhatt DL, Ginwalla M. Effect of influenza on outcomes in patients with heart failure. JACC Heart Fail. 2019;7(2):112–17. doi:10.1016/j.jchf.2018.10.011.
- Thomsen RW, Kasatpibal N, Riis A, Norgaard M, Sorensen HT. The impact of pre-existing heart failure on pneumonia prognosis: population-based cohort study. J Gen Intern Med. 2008;23(9):1407–13. doi:10.1007/s11606-008-0672-3.
- Barnes M, Heywood AE, Mahimbo AR, Rahman B, Newall AT, Macintyre CR. Acute myocardial infarction and influenza: a meta-analysis of case–control studies. Heart. 2015;101(21):1739–47. doi:10.1136/heartjnl-2015-307691.
- Smeeth L, Thomas SL, Hall AJH, Hubbard R, Farrington P, Vallance P, et al. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med. 2004;351(25):2611–18. doi:10.1056/NEJMoa041747.
- Toniolo A, Cassani G, Puggioni A, Rossi A, Colombo A, Onodera T, Ferrannini E. The diabetes pandemic and associated infections: suggestions for clinical microbiology. Rev Med Microbiol. 2019;30(1):1–17. doi:10.1097/MRM.0000000000000155.
- Mertz D, Kim TH, Johnstone J, Lam PP, Science M, Kuster SP, Fadel SA, Tran D, Fernandez E, Bhatnagar N, et al. Populations at risk for severe or complicated influenza illness: systematic review and meta-analysis. BMJ. 2013;347:f5061. doi:10.1136/bmj.f5061.
- Abubakar I, Tillmann T, Banerjee A. Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the global burden of disease study 2013. Lancet. 2015;385(9963):117–71. doi:10.1016/S0140-6736(14)61682-2.
- Hewitt R, Farne H, Ritchie A, Luke E, Johnston SL, Mallia P. The role of viral infections in exacerbations of chronic obstructive pulmonary disease and asthma. Ther Adv Respir Dis. 2016;10(2):158–74. doi:10.1177/1753465815618113.
- Frickmann H, Jungblut S, Hirche TO, Gross U, Kuhns M, Zautner AE. The influence of virus infections on the course of COPD. Eur J Microbiol Immunol. 2012;2(3):176–85. doi:10.1556/EuJMI.2.2012.3.2.
- Zhang X, Zhu X, Ji Y, Li H, Hou F, Xiao C, Yuan P. Increased risk of hepatitis B virus infection amongst individuals with diabetes mellitus. Biosci Rep. 2019;39(3):BSR20181715. doi:10.1042/BSR20181715.
- Seshasai SRK, Kaptoge S, Thompson A, Angelantonio ED, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med. 2011;364(9):829–41. doi:10.1056/NEJMoa1008862.
- Syed-Ahmed M, Narayana M. Immune dysfunction and risk of infection in chronic kidney disease. Adv Chronic Kidney Dis. 2019;26(1):8–15. doi:10.1053/j.ackd.2019.01.004.
- Casqueiro J, Casqueiro J, Alves C. Infections in patients with diabetes mellitus: a review of pathogenesis. Indian J Endocrinol Metab. 2012;16(Suppl 1):S27–36. doi:10.4103/2230-8210.94253.
- World Health Organization. Global status report on noncommunicable diseases. Geneva: World Health Organization; 2010. [accessed 2021 July]. https://www.who.int/nmh/publications/ncd_report_full_en.pdf .
- Ritchie H, Roser M. Age structure; 2019. [accessed 2021 July]. https://ourworldindata.org/age-structure .
- He W, Goodkind D, Kowal P. An aging world: 2015 - International population reports. Washington (DC); 2016. [accessed 2021 July]. https://www.census.gov/content/dam/Census/library/publications/2016/demo/p95-16-1.pdf .
- World Health Organization. Ageing and health; 2018. [accessed 2021 July]. https://www.who.int/news-room/fact-sheets/detail/ageing-and-health .
- World Health Organization. COVID-19 and the decade of healthy ageing; 2020. [accessed 2021 July]. https://www.who.int/docs/default-source/decade-of-healthy-ageing/decade-connection-series---covid-19-en.pdf?sfvrsn=d3f887b0_7 .
- Clarfield A, Jotkowitz A. Age, ageing, ageism and “age-itation” in the age of COVID-19: rights and obligations relating to older persons in Israel as observed through the lens of medical ethics. Isr J Health Policy Res. 2020;9(1):64. doi:10.1186/s13584-020-00416-y.
- Torres A, Blasi F, Dartois N, Akova M. Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease. Thorax. 2015;70(10):984–89. doi:10.1136/thoraxjnl-2015-206780.
- Zwaans WAE, Mallia PW. The relevance of respiratory viral infections in the exacerbations of chronic obstructive pulmonary disease - a systematic review. J Clin Virol. 2014;61(2):181–88. doi:10.1016/j.jcv.2014.06.025.
- Salam N, Rane S, Das R, Faulkner M, Gund R, Kandpal U, Lewis V, Mattoo H, Prabhu S, Ranganathan V, et al. T cell ageing: effects of age on development, survival & function. Indian J Med Res. 2013;138(5):595–608.
- Pothineni NVK, Subramany S, Kuriakose K, Shirazi LF, Romeo F, Shah PK, Mehta JL. Infections, atherosclerosis, and coronary heart disease. Eur Heart J. 2017;38(43):3195–201. doi:10.1093/eurheartj/ehx362.
- Ishigami J, Matsushita K. Clinical epidemiology of infectious disease among patients with chronic kidney disease. Clin Exp Nephrol. 2019;23(4):437–47. doi:10.1007/s10157-018-1641-8.
- Arokiasamy P. India’s escalating burden of non-communicable diseases. Lancet Glob Health. 2018;6(12):E1262. doi:10.1016/S2214-109X(18)30448-0.
- Sinha R, Pati S. Addressing the escalating burden of chronic diseases in India: Need for strenthening primary care. J Family Med Prim Care. 2017;6(4):701–08. doi:10.4103/jfmpc.jfmpc_1_17.
- World Health Organization. Noncommunicable diseases: country profiles 2018. 2018. [accessed 2021 July]. https://www.who.int/nmh/publications/ncd-profiles-2018/en/ .
- Mahal A, Karan A, Engelgau M The economic implications of non-communicable disease for India. HNP discussion paper. Washington (DC): The World Bank; 2010. [accessed 2022 February]. https://openknowledge.worldbank.org/handle/10986/13649 .
- Verma R, Khanna P, Chawla S. Adult immunization in India: Importance and recommendations. Hum Vaccin Immunother. 2015;11(9):2180–82. doi:10.4161/hv.29342.
- Ministry of Home Affairs. Report on medical certification of cause of death 2017. [accessed 2021 July]. https://www.censusindia.gov.in/2011-Documents/mccd_Report1/MCCD_Report-2017.pdf .
- Emsley HCA, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab. 2002;22(12):1399–419. doi:10.1097/01.WCB.0000037880.62590.28.
- Madjid M, Aboshady I, Awan I, Litovsky S, Casscekks SW. Influenza and cardiovascular disease: is there a casual relationship? Tex Heart Inst J. 2004;31(1):4–13.
- Nagel MA, Gilden D. The relationship between herpes zoster and stroke. Curr Neurol Neurosci Rep. 2015;15(4):16. doi:10.1007/s11910-015-0534-4.
- Tadic M, Cuspidi C, Grassi G. Heart rate as a predictor of cardiovascular risk. Eur J Clin Invest. 2018;48(3):e12892. doi:10.1111/eci.12892.
- Wu PH, Chuang YS, Lin YT. Does herpes zoster increase the risk of stroke and myocardial infarction? A comprehensive review. J Clin Med. 2019;8(4):547. doi:10.3390/jcm8040547.
- Nguyen JL, Yang W, Ito K, Matte TD, Shaman J, Kinney PL. Seasonal influenza infections and cardiovascular disease mortality. JAMA Cardiol. 2018;1(3):274–81. doi:10.1001/jamacardio.2016.0433.
- World Health Organization. Chronic obstructive pulmonary disease (COPD); 2017. [accessed 2021 July]. https://www.who.int/news-room/fact-sheets/detail/chronic-obstructive-pulmonary-disease-(copd)
- Suissa S, Dell’Aniello S, Ernst P. Long-Term natural histroy of chronic obstructive pulmonary disease: severe exacerbations and mortality. Thorax. 2012;67(11):957–63. doi:10.1136/thoraxjnl-2011-201518.
- Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2020. [accessed 2021 July]. https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf .
- Rothnie KJ, Connell O, Mullerova H, Smeeth L, Pearce N, Douglas I, Quint JK. Myocardial infarction and ischemic stroke after exacerbations of chronic obstrutcive pulmonary disease. Ann Am Thorac Soc. 2018;15(8):935–46. doi:10.1513/AnnalsATS.201710-815OC .
- O’Byrne PM, Pedersen S, Lamm CJ, Tan WC, Busse W. Severe exacerbations and decline in lung function in asthma. Am J Respir Crit Care Med. 2009;179(1):19–24. doi:10.1164/rccm.200807-1126OC .
- Raita Y, Camargo CA, Faridi MK, Brown DFM, Shimada YJ, Hasegawa K. Risk of acute myocardial infarction and ischemic stroke in patients with asthma exacerbation: a population-based, self-controlled case series study. J Allergy Clin Immunol Pract. 2020;8(1):188–94. doi:10.1016/j.jaip.2019.06.043.
- Grissell TV, Powell H, Shafren DR, Boyle MJ, Hensley MJ, Jones PD, Whitehead BF, Gibson PG. Interleukin-10 gene expression in acute virus-induced asthma. Am J Respir Crit Care Med. 2005;172(4):433–39. doi:10.1164/rccm.200412-1621OC.
- Wark PAB, Tooze M, Powell H, Parsons K. Viral and bacterial infection in acute asthma and chronic obstructive pulmonary disease increases the risk of readmission. Respirology. 2013;18(6):996–1002. doi:10.1111/resp.12099.
- Ko FW, Chan KP, Hui DS, Goddard JR, Shaw JG, Reid DW, Yang IA. Acute exacerbation of COPD. Respirology. 2016;21(7):1152–65. doi:10.1111/resp.12780.
- Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, et al. Factors associated with poor outcomes among adults hospitalizaed for influenza in France: a three-year prospective multicenter study. J Clin Virol. 2016;79:68–73. doi:10.1016/j.jcv.2016.04.005.
- Chacon R, Mirza S, Rodriguez D, Paredes A, Guzman G, Moreno L, Then CJ, Jara J, Blanco N, Bonilla L, et al. Demographic and clinical characteristics of deaths associated with influenza A(H1N1) pdm09 in Central America and Dominican Republic 2009–2010. BMC Public Health. 2015;15(1):734. doi:10.1186/s12889-015-2064-z.
- Pebody RG, McLean E, Zhao H, Cleary P, Bracebridge S, Foster K, Charlett A, Hardelid P, Waight P, Ellis J, et al. Pandemic influenza a (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill. 2010;15(20):19571. doi:10.2807/ese.15.20.19571-en.
- Santa-Olalla Peralta P, Cortes-Garcia M, Vicente-Herrero M, Castrillo-Villamandos C, Arias-Bohigas P, Pachon-Del Amo I, Sierra-Moros MJ. Risk factors for disease severity among hospitalised patients with 2009 pandemic influenza a (H1N1) in Spain, April – December 2009. Euro Surveill. 2010;15(38):19667. doi:10.2807/ese.15.38.19667-en.
- Yamada K, Elliott WM, Hayashi S, Brattsand R, Roberts C, Vitalis TZ, Hogg JC. Latent adenoviral infection modifies the steroid response in allergic lung inflammation. J Allergy Clin Immunol. 2000;106(5):844–51. doi:10.1067/mai.2000.110473.
- Hogg JC. Role of latent viral infections in chronic obstructive pulmonary disease and asthma. Am J Respir Crit Care Med. 2001;164(Suppl 2):S71–S5. doi:10.1164/ajrccm.164.supplement_2.2106063.
- De Serres G, Lampron N, La Forge J, Rouleau I, Bourbeau J, Weiss K, Barret B, Boivin G. Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations. J Clin Virol. 2009;46(2):129–33. doi:10.1016/j.jcv.2009.07.010.
- India State-Level Disease Burden Initiative Diabetes Collaborators. The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990–2016. Lancet Glob Health. 2018;6(12):e1352–62. doi:10.1016/S2214-109X(18)30387-5.
- Weiner DE, Tighiouart H, Amin MG, Stark PC, MacLeod B, Griffith JL, et al. Chronic kidney disease as a risk factor for cardiovascular disease and all-cause mortality: a pooled analysis of community-based studies. J Am Soc Nephrol. 2004;15(5):1307–15. doi:10.1097/01.ASN.0000123691.46138.E2.
- Centers for Disease Control and Prevention. Heart disease, stroke, or other cardiovascular disease and adult vaccination; 2016. [accessed 2021 July]. https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/heart-disease.html .
- Wang Y, Cheng M, Wang S, Wu F, Yan Q, Yang Q, Li Y, Guo X, Fu C, Shi Y, et al. Vaccination coverage with the pneumococcal and influenza vaccine among persons with chronic diseases in Shanghai, China, 2017. BMC Public Health. 2020;20(1):359. PMC7081528. doi:10.1186/s12889-020-8388-3.
- 23-valentpneumococcal polysaccharide vaccine. WHO position paper. Wkly Epidemiol Rec. 2008;83( 42):373–84.
- NHS England. Directed enhanced service specification. Seasonal influenza and pneumococcal polysaccharide vaccination programme 2019/20; 2019. [accessed 2021 July]. https://www.england.nhs.uk/wp-content/uploads/2019/03/dess-sfl-and-pneumococcal-1920.pdf .
- Davis MM, Taubert K, Benin AL, Brown DW, Mensah GA, Baddour LM, Dunbar S, Krumholz HM. Influenza vaccination as secondary prevention for cardiovascular disease: a science advisory from the American Heart Association/American College of Cardiology. J Am Coll Cardiol. 2006;48(7):1498–502. doi:10.1016/j.jacc.2006.09.004.
- Piepoli M, Hoes AW, Agewall S, Albus C, Brotons C, Catapano AL, Cooney M-T, Corrà U, Cosyns B, Deaton C, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur Heart J. 2016;37(29):2315–81. doi:10.1093/eurheartj/ehw106.
- World Health Organization. Recommendations on influenza vaccination during the 2019–2020 winter season; 2019. [accessed 2021 July]. https://www.euro.who.int/__data/assets/pdf_file/0017/413270/Influenza-vaccine-recommendations-2019-2020_en.pdf .
- Gabutti G, Bolognesi N, Sandri F, Florescu C, Stefanati A. Varicella zoster virus vaccines: an update. Immunotargets Ther. 2019;8:15–28. doi:10.2147/ITT.S176383.
- Klaric JS, Beltran TA, McClenathan BM. An association between herpes zoster vaccination and stroke reduction among elderly individuals. Mil Med. 2019;184(Suppl 1):126–32. doi:10.1093/milmed/usy343.
- World Health Organization. Prevention and control of influenza pandemics and annual epidemics; 2003. [accessed 2021 July]. https://www.who.int/immunization/sage/1_WHA56_19_Prevention_and_control_of_influenza_pandemics.pdf .
- World Health Organization. Summary of WHO position papers - Recommendations for routine immunization; 2020. [accessed 2021 July]. https://www.who.int/immunization/policy/Immunization_routine_table1.pdf .
- Centers for Disease Control and Prevention. National Center for Immunization and Respiratory Diseases. Renal disease and adult vaccination. Washington (DC): Office of the Associate Director for Communication, Digital Media Branch, Division of Public Affairs; 2016. [accessed 2021 July]. https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/renal-disease.html .
- Public Health England. Complete routine immunisation; 2020. [accessed 2021 July]. https://www.gov.uk/government/publications/the-complete-routine-immunisation-schedule .
- Centers for Disease Control and Prevention. Vaccinations for adults with lung disease; 2016. [accessed 2021 July]. https://www.cdc.gov/vaccines/adults/rec-vac/health-conditions/lung-disease.html .
- Centers for Disease Control and Prevention. Herpes zoster vaccination; 2015. [accessed 2021 July]. https://www.cdc.gov/vaccines/vpd/shingles/hcp/zostavax/hcp-vax-recs.html#:~:text=CDC%20recommends%20a%20single%20dose,precaution%20exists%20for%20their%20condition .
- Centers for Disease Control and Prevention. Pneumocococcal vaccination: Summary of who and when to vaccinate; 2019. [accessed 2021 July]. https://www.cdc.gov/vaccines/vpd/pneumo/hcp/who-when-to-vaccinate.html .
- Centers for Disease Control and Prevention. Estimates of influenza vaccination coverage among adults - United States, 2017-18 Flu season; 2018. [accessed 2021 July]. https://www.cdc.gov/flu/fluvaxview/coverage-1718estimates.htm .
- Public Health England. Seasonal influenza vaccine uptake in GP patients: winter season 2018 to 2019; 2019. [accessed 2021 July]. https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/804889/Seasonal_influenza_vaccine_uptake_in_GP_patients_1819.pdf .
- NHS. Who should have the pneumococcal vaccine; 2019. [accessed 2021 July]. https://www.nhs.uk/conditions/vaccinations/when-is-pneumococcal-vaccine-needed/#:~:text=Adults%20aged%2065%20or%20over,serious%20forms%20of%20pneumococcal%20infection .
- NHS. Flu vaccine; 2020. [accessed 2021 July]. https://www.nhs.uk/conditions/vaccinations/flu-influenza-vaccine/ .
- NHS. Who can have the shingles vaccine? [accessed 2021 July]. https://www.nhs.uk/conditions/vaccinations/who-can-have-the-shingles-vaccine/ .
- NHS. Hepatitis B vaccine overview; 2018. [accessed 2021 July]. https://www.nhs.uk/conditions/vaccinations/hepatitis-b-vaccine/ .
- Wankhedkar R, Tandon RN, Monga VK. Indian medical association: Life course immunization guidebook: a quick reference guide; 2018. [accessed 2021 July]. http://www.ima-india.org/ima/pdfdata/IMA_LifeCourse_Immunization_Guide_2018_DEC21.pdf .
- Aguado MT, Barratt J, Beard JR, Blomberg BB, Chen WH, Hickling J, Hyde TB, Jit M, Jones R, Poland GA, et al. Report on WHO meeting on immunization in older adults: Geneva, Switzerland, 22–23 March 2017. Vaccine. 2018;36(7):921–31. doi:10.1016/j.vaccine.2017.12.029 .
- Michel JP, Gusmano M, Blank PR, Philp I. Vaccination and healthy ageing: How to make life-course vaccination a successful public health strategy. Eur Geriatr Med. 2010;1(3):155–65. doi:10.1016/j.eurger.2010.03.013.
- Gardner ID. The effect of aging on susceptibility to infection. Rev Infect Dis. 1980;2(5):801–10. doi:10.1093/clinids/2.5.801.
- Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, Franceschi C, Lithgow GJ, Morimoto RI, Pessin JE, et al. Aging: a common driver of chronic diseases and a target for novel interventions. Cell. 2014;159(4):709–13. doi:10.1016/j.cell.2014.10.039.
- Bektas A, Schurman SH, Sen R, Ferrucci L. Aging, inflammation and the environment. Exp Gerontol. 2018;105:10–18. doi:10.1016/j.exger.2017.12.015.
- World Health Organization. World report on ageing and health; 2015. [accessed 2021 July]. https://apps.who.int/iris/bitstream/handle/10665/186463/9789240694811_eng.pdf;jsessionid=8203501201A6360D0E1D3273FC0618AA?sequence=1 .
- Clar C, Oseni Z, Flowers N, Keshtkar-Jahromi M, Rees K. Influenza vaccines for preventing cardiovascular disease. Cochrane Database Syst Rev. 2015;5(5):CD005050. doi:10.1002/14651858.CD005050.pub3.
- Lee KR, Bae JH, Hwang IC, Kim KK, Suh HS, Ko KD. Effect of influenza vaccination on risk of stroke: a systematic review and meta-analysis. Neuroepidemiology. 2017;48(3–4):103–10. doi:10.1159/000478017.
- Vila-Corcoles A, Ochoa-Gondar O, Rodriguez-Blanco T, Gutierrez-Perez A, Vila-Rovira A, Gomez F, Raga X, de Diego C, Satue E, Salsench E, et al. Clinical effectiveness of pneumococcal vaccination against acute myocardial infarction and stroke in people over 60 years: the CAPAMIS study, one-year follow-up. BMC Public Health. 2012;12(1):222. doi:10.1186/1471-2458-12-222.
- Ren S, Newby D, Li SC, Walkom E, Miller P, Hure A, Attia J. Effect of the adult pneumococcal polysaccharide vaccine on cardiovascular disease: a systematic review and meta-analysis. Open Heart. 2015;2(1):e000247. doi:10.1136/openhrt-2015-000247.
- Kopel E, Klempfner R, Goldenberg I. Influenza vaccine and survival in acute heart failure. Eur J Heart Fail. 2014;16(3):264–70. doi:10.1002/ejhf.14.
- Wu W-C, Jiang L, Friedmann PD, Trivedi A. Association between process quality measures for heart failure and mortality among US veterans. Am Heart J. 2014;168(5):713–20. doi:10.1016/j.ahj.2014.06.024.
- Vardeny O, Claggett B, Udell JA, Packer M, Zile M, Rouleau J, Swedberg K, Desai AS, Lefkowitz M, Shi V, et al. Influenza vaccination in patients with chronic heart failure. JACC Heart Fail. 2016;4(2):152–58. doi:10.1016/j.jchf.2015.10.012.
- Liu IF, Huang CC, Chan WL, Huang PH, Chung CM, Lin SJ, Chen J-W, Leu H-B. Effects of annual influenza vaccination on mortality and hospitalization in elderly patients with ischemic heart disease: a nationwide population-based study. Prev Med. 2012;54(6):431–33. doi:10.1016/j.ypmed.2012.03.020.
- Kaya H, Beton O, Acar G, Temizhan A, Cavusoğlu Y, Guray U, Zoghi M, Ural D, Ekmekci A, Gungor H, et al. Influence of influenza vaccination on recurrent hospitalization in patients with heart failure. Herz. 2017;42(3):307–15. doi:10.1007/s00059-016-4460-2.
- Vila-Córcoles A, Ochoa O, de Diego C, Valdivieso A, Herreros I, Bobé F, Alvarez M, Juárez M, Guinea I, Ansa X, et al. Effects of annual influenza vaccination on winter mortality in elderly people with chronic pulmonary disease. Int J Clin Pract. 2008;62(1):10–17. doi:10.1111/j.1742-1241.2007.01414.x.
- Blaya-Nováková V, Prado-Galbarro FJ, Sarría-Santamera A. Effects of annual influenza vaccination on mortality in patients with heart failure. Eur J Public Health. 2016;26(5):890–92. doi:10.1093/eurpub/ckw141.
- Mohseni H, Kiran A, Khorshidi R, Rahimi K. Influenza vaccination and risk of hospitalization in patients with heart failure: a self-controlled case series study. Eur Heart J. 2017;38(5):326–33. doi:10.1093/eurheartj/ehw411.
- Poudel S, Shehadeh F, Zacharioudakis IM, Tansarli GS, Zervou FN, Kalligeros M, van Aalst R, Chit A, Mylonakis E. The effect of influenza vaccination on mortality and risk of hospitalization in patients with heart failure: a systematic review and meta-analysis. Open Forum Infect Dis. 2019;6(4):ofz159. doi:10.1093/ofid/ofz159.
- Naghavi M, Barlas Z, Siadaty S, Naguib S, Madjid M, Casscells W. Association of influenza vaccination and reduced risk of recurrent myocardial infarction. Circulation. 2000;102(25):3039–45. doi:10.1161/01.cir.102.25.3039.
- Menon B, Gurnani M, Aggarwal B. Comparison of outpatient visits and hospitalisations, in patients with chronic obstructive pulmonary disease, before and after influenza vaccination. Int J Clin Pract. 2008;62(4):593–98. doi:10.1111/j.1742-1241.2007.01641.x.
- Chen KY, Wu SM, Liu JC, Lee KY. Effect of annual influenza vaccination on reducing lung cancer in patients with chronic obstructive pulmonary disease from a population-based cohort study. Medicine (Baltimore). 2019;98(47):e18035. doi:10.1097/MD.0000000000018035.
- Sung LC, Chen CI, Fang YA, Lai CH, Hsu YP, Cheng TH, Miser JS, Liu J-C. Influenza vaccination reduces hospitalization for acute coronary syndrome in elderly patients with chronic obstructive pulmonary disease: a population-based cohort study. Vaccine. 2014;32(30):3843–49. doi:10.1016/j.vaccine.2014.04.064.
- Santos G, Tahrat H, Bekkat-Berkani R. Immunogenicity, safety, and effectiveness of seasonal influenza vaccination in patients with diabetes mellitus: a systematic review. Hum Vaccin Immunother. 2018;14(8):1853–66. doi:10.1080/21645515.2018.1446719.
- Vamos EP, Pape UJ, Curcin V, Harris MJ, Valabhji J, Majeed A, Millett C. Effectiveness of the influenza vaccine in preventing admission to hospital and death in people with type 2 diabetes. CMAJ. 2016;188(14):E342–E51. doi:10.1503/cmaj.151059.
- Rodriguez-Blanco T, Vila-Corcoles A, de Diego C, Ochoa-Gondar O, Valdivieso E, Bobe F, Morro A, Herńndez N, Martin A, Calamote F, et al. Relationship between annual influenza vaccination and winter mortality in diabetic people over 65 years. Hum Vaccin Immunother. 2012;8(3):363–70. doi:10.4161/hv.18548.
- Wang I, Lin C, Chang Y, Lin P, Liang C, Liu Y, Chang C-T, Yen T-H, Huang C-C, Sung F-C, et al. Effectiveness of influenza vaccination in elderly diabetic patients: a retrospective cohort study. Vaccine. 2013;31(4):718–24. doi:10.1016/j.vaccine.2012.11.017.
- Fang YA, Chen CI, Liu JC, Sung LC. Influenza vaccination reduces hospitalization for heart failure in elderly patients with chronic kidney disease: a population-based cohort study. Acta Cardiol Sin. 2016;32(3):290–98. doi:10.6515/acs20150424l.
- Chen CI, Kao PF, Wu MY, Fang YA, Miser JS, Liu JC, Sung L-C. Influenza vaccination is associated with lower risk of acute coronary syndrome in elderly patients with chronic kidney disease. Medicine (Baltimore). 2016;95(5):e2588. doi:10.1097/MD.0000000000002588.
- Huang J, Ou HY, Lin J, Karnchanasorn R, Feng W, Samoa R, Chuang L-M, Chiu KC. The impact of hepatits B vaccination status on the risk of diabetes, implicating diabetes risk reduction by successful vaccination. PLOS One. 2015;10(10):e0139730. doi:10.1371/journal.pone.0139730.
- Kuhtreiber WM, Tran L, Kim T, Dybala M, Nguyen B, Plager S, Huang D, Janes S, Defusco A, Baum D, et al. Long-term reduction in hyperglycemia in advanced type 1 diabetes: the value of induced aerobic glycolysis with BCG vaccinations. NPJ Vaccines. 2018;3(1):23. doi:10.1038/s41541-018-0062-8.
- National Health Portal India. Universal Immunisation Programme. [accessed 2022 January]. https://www.nhp.gov.in/universal-immunisation-programme_pg .
- Dash R, Agrawal A, Nagvekar V, Lele J, Di Pasquale A, Kolhapure S, Parikh R. Towards adult vaccination in India: a narrative literature review. Hum Vaccin Immunother. 2020;16(4):991–1001. doi:10.1080/21645515.2019.1682842.
- Ramasubramanian V. Adult immunization in India; 2019. [accessed 2022 February]. https://apiindia.org/wp-content/uploads/pdf/progress_in_medicine_2017/mu_06.pdf .
- Muruganathan A, Mathai D, Sharma SK. Adult immunization. New Delhi (India): The Association of Physicians of India Jaypee Brothers Medical Publishers; 2014.
- Guidelines for vaccination in normwal adults in India. Indian J Nephrol. 2016;26(Suppl 1):S7–S14.
- Federation of Obstetric & Gynaecological Societies of India. Good clinical practice recommendations on preconception; 2016. [accessed 2022 February]. https://www.fogsi.org/wp-content/uploads/2016/09/FOGSI-PCCR-Guideline-Booklet-Orange.pdf .
- Federation of Obstetric & Gynaecological Societies of India. Vaccination in women; 2015. [accessed 2022 February]. https://www.fogsi.org/wp-content/uploads/2015/11/vaccination_women.pdf .
- Smith LE, Webster RK, Weinman J, Amlôt R, Yiend J, Rubin J. Psychological factors associated with uptake of the childhood influenza vaccine and perception of post-vaccination side effects: a cross-sectional survey in England. Vaccine. 2017;35(15):1936–45. doi:10.1016/j.vaccine.2017.02.031.
- Doherty TM, Giudice GD, Maggi S. Adult vaccination as part of a healthy lifestyle: moving from medical intervention to health promotion. Ann Med. 2019;51(2):128–40. doi:10.1080/07853890.2019.1588470.
- Telford R, Rogers A. What influences elderly peoples’ decisions about whether to accept the influenza vaccination? a qualitative study. Health Educ Res. 2003;18(6):743–53. doi:10.1093/her/cyf059.
- Lytras T, Kopsachilis F, Mouratidou E, Papamichail D, Bonovas S. Interventions to increase seasonal influenza vaccine coverage in healthcare workers: a systematic review and meta-regression analysis. Hum Vaccin Immunother. 2016;12(3):671–81. doi:10.1080/21645515.2015.1106656.
- Sheikh S, Biundo E, Courcier S, Damm O, Launay O, Maes E, Marcos C, Matthews S, Meijer C, Poscia A, et al. A report on the status of vaccination in Europe. Vaccine. 2018;36(33):4979–92. doi:10.1016/j.vaccine.2018.06.044.
- Bagcchi S. India tackles vaccine preventable diseases. Lancet Infect Dis. 2015;15(6):637–38. doi:10.1016/S1473-3099(15)00009-2.
- John TJ, Dandona L, Sharma VP, Kakkar M. Continuing challenge of infectious diseases in India. Lancet. 2011;377(9761):252–69. doi:10.1016/S0140-6736(10)61265-2.
- TENNEWS.in. Majority of Indians are unaware of adult vaccinations; 2017. [accessed 2022 January]. https://tennews.in/majority-indians-unaware-adult-vaccinations/ .
- Nethan S, Sinha D, Mehrotra R. Non communicable disease risk factors and their trends in India. Asian Pac J Cancer Prev. 2017;18(7):2005–10. doi:10.22034/APJCP.2017.18.7.2005.
- Philip RK, Attwell K, Breuer T, Di Pasquale A, Lopalco PL. Life-course immunization as a gateway to health. Expert Rev Vaccines. 2018;17(10):851–64. doi:10.1080/14760584.2018.1527690.
- Lahariya C, Bhardwaj P. Adult vaccination in India: status and the way forward. Hum Vaccin Immunother. 2020;16(7):1508–10. doi:10.1080/21645515.2019.1692564.
- Lin CJ, Nowalk MP, Pavlik VN, Brown AE, Zhang S, Raviotta JM, Moehling KK, Hawk M, Ricci EM, Middleton DB, et al. Using the 4 pillars™ practice transformation program to increase adult influenza vaccination and reduce missed opportunities in a randomized cluster trial. BMC Infect Dis. 2016;16(1):623. doi:10.1186/s12879-016-1940-1.
- Nowalk MP, Moehling KK, Zhang S, Raviotta JM, Zimmerman RK, Lin CJ. Using the 4 pillars to increase vaccination among high-risk adults: Who benefits? Am J Manag Care. 2017;23(11):651–55.
- World Health Organization SAGE Working group dealing with vaccine hesitancy. Strategies for addressing vaccine hesitancy – a systematic review; 2014. [accessed 2022 January]. https://www.who.int/immunization/sage/meetings/2014/october/3_SAGE_WG_Strategies_addressing_vaccine_hesitancy_2014.pdf.